- Home
- LNTH vs LEGN Comparison
LNTH vs LEGN Comparison
Compare LNTH & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- LEGN
- Stock Information
- Founded
- LNTH 1956
- LEGN 2014
- Country
- LNTH United States
- LEGN United States
- Employees
- LNTH N/A
- LEGN N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- LNTH Health Care
- LEGN Health Care
- Exchange
- LNTH Nasdaq
- LEGN Nasdaq
- Market Cap
- LNTH 7.5B
- LEGN 7.0B
- IPO Year
- LNTH 2015
- LEGN 2020
- Fundamental
- Price
- LNTH $73.86
- LEGN $28.91
- Analyst Decision
- LNTH Strong Buy
- LEGN Strong Buy
- Analyst Count
- LNTH 5
- LEGN 13
- Target Price
- LNTH $133.80
- LEGN $75.67
- AVG Volume (30 Days)
- LNTH 1.5M
- LEGN 1.7M
- Earning Date
- LNTH 05-07-2025
- LEGN 05-13-2025
- Dividend Yield
- LNTH N/A
- LEGN N/A
- EPS Growth
- LNTH N/A
- LEGN N/A
- EPS
- LNTH 3.53
- LEGN N/A
- Revenue
- LNTH $1,536,699,000.00
- LEGN $728,303,000.00
- Revenue This Year
- LNTH $4.63
- LEGN $64.21
- Revenue Next Year
- LNTH $9.35
- LEGN $53.69
- P/E Ratio
- LNTH $20.92
- LEGN N/A
- Revenue Growth
- LNTH 12.53
- LEGN 112.46
- 52 Week Low
- LNTH $73.11
- LEGN $27.34
- 52 Week High
- LNTH $126.89
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- LNTH 26.09
- LEGN 39.95
- Support Level
- LNTH $73.11
- LEGN $28.14
- Resistance Level
- LNTH $81.50
- LEGN $31.12
- Average True Range (ATR)
- LNTH 3.44
- LEGN 1.87
- MACD
- LNTH -1.23
- LEGN -0.16
- Stochastic Oscillator
- LNTH 2.10
- LEGN 25.95
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.